INTERCEPT PHARMACEUTICALS, INC. Annual Return On Assets in % from 2013 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2013 to 2022.
  • Intercept Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2023 was -12.7 %, a 132% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Return On Assets for 2022 was 42 %.
  • Intercept Pharmaceuticals, Inc. annual Return On Assets for 2021 was -17.5 %, a 60.7% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Return On Assets for 2020 was -44.5 %, a 8.1% increase from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 42 +59.4 Jan 1, 2022 Dec 31, 2022
2021 -17.5 +27 +60.7% Jan 1, 2021 Dec 31, 2021
2020 -44.5 +3.92 +8.1% Jan 1, 2020 Dec 31, 2020
2019 -48.4 +11.5 +19.2% Jan 1, 2019 Dec 31, 2019
2018 -59.9 +2 +3.23% Jan 1, 2018 Dec 31, 2018
2017 -61.9 -0.04 -0.07% Jan 1, 2017 Dec 31, 2017
2016 -61.9 -26.3 -74% Jan 1, 2016 Dec 31, 2016
2015 -35.6 +78.6 +68.8% Jan 1, 2015 Dec 31, 2015
2014 -114 -67.3 -144% Jan 1, 2014 Dec 31, 2014
2013 -46.8 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.